Article
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.
Molecular oncology - 1 Jan 2021
Romero Atocha, Jantus-Lewintre Eloisa, García-Peláez Beatriz, Royuela Ana, Insa Amelia, Cruz Patricia, Collazo Ana, Pérez Altozano Javier, Vidal Oscar Juan, Diz Pilar, Cobo Manuel, Hernández Berta, Vázquez Estevez Sergio, Benítez Gretel, Guirado Maria, Majem Margarita, Bernabé Reyes, Ortega Ana Laura, Blasco Ana, Bosch-Barrera Joaquim, Jurado Jose M, García González Jorge, Viteri Santiago, Garcia Giron Carlos, Massutí Bartomeu, Lopez Martín Ana, Rodriguez-Festa Alejandro, Calabuig-Fariñas Silvia, Molina-Vila Miguel Ángel, Provencio Mariano
Abstract excerpt
Several platforms for noninvasive EGFR testing are currently used in the clinical setting with sensitivities ranging from 30% to 100%. Prospective studies evaluating agreement and sources for discordant results remain lacking. Herein, seven methodologies including two next-generation sequencing (NGS)-based methods, three high-sensitivity PCR-based platforms, and two FDA-approved methods were compared using 72...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
